Efficacy and safety of obinutuzumab in refractory membranous nephropathy: a single-arm meta-analysis. | ClinicLens
Membranous nephropathy (MN) constitutes an autoimmune glomerular disorder and represents the most frequent etiology of primary nephrotic syndrome in adults. Although obinutuzumab exhibits favorable efficacy in managing refractory MN, outcomes diverge across individual investigati
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.